+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market - Global Forecast 2026-2032- Product Image
Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market - Global Forecast 2026-2032- Product Image
Sale

Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6147965
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market is projected to reach USD 254.40 Million in 2026. It is expected to continue growing at a CAGR of 6.96%, reaching USD 379.41 Million by 2032.

Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccines: Executive Overview

Porcine circovirus and Mycoplasma hyopneumoniae are important contributors to respiratory and multisystem disease complexes in swine. Vaccination strategies increasingly address both pathogens within broader herd-health programs that also include biosecurity, diagnostics, antimicrobial stewardship, nutrition, and production management. Product selection depends on disease pressure, pig-flow design, maternal-antibody considerations, administration requirements, veterinary oversight, and the regulatory framework in each market.

Integrated Herd Health Is Reshaping Vaccine Use

The landscape is shifting from pathogen-specific treatment toward preventive, protocol-based herd health. Producers are placing greater emphasis on early-life protection, consistent administration, monitoring of respiratory performance, and coordination between breeding, nursery, and finishing units. Additional change is being driven by pressure to reduce avoidable antimicrobial use, improve traceability, strengthen biosecurity, and maintain productivity despite movement restrictions, labor constraints, and variable disease exposure.

Artificial Intelligence Supports Surveillance and Protocol Decisions

Artificial intelligence can strengthen this field by combining clinical observations, mortality records, growth data, feed conversion, environmental readings, laboratory results, and vaccination records. Pattern-recognition tools may help identify unusual respiratory trends, prioritize diagnostic sampling, and detect deviations from expected post-vaccination performance. However, AI outputs require high-quality farm data, veterinary validation, explainable decision rules, and safeguards against confusing correlation with causation. AI should support-not replace-laboratory confirmation and professional judgment.

Regional Conditions Shape Prevention Priorities

In North America, vertically coordinated production and established veterinary infrastructure support standardized vaccination and monitoring, while antimicrobial stewardship and respiratory-complex management remain central. Latin America combines expanding pork production with varied farm formalization, cold-chain reliability, and veterinary access, making practical administration and technical support important. Europe emphasizes animal welfare, antimicrobial reduction, traceability, and stringent regulatory compliance. The Middle East requires attention to import controls, local production structures, and veterinary capacity. Africa presents highly diverse systems, from commercial operations to smallholder production, with biosecurity, diagnostics, and cold-chain access often determining implementation. Asia-Pacific includes major swine-producing markets and highly heterogeneous production systems, so disease pressure, farm scale, regulatory pathways, and local manufacturing capabilities differ substantially across countries.

Economic and Policy Groups Reveal Shared Implementation Challenges

Across ASEAN, varied production scales, cross-border trade, and uneven veterinary infrastructure make harmonized protocols and regional disease surveillance valuable. BRICS countries span major production bases and diverse regulatory environments, creating opportunities for locally adapted vaccination programs and stronger diagnostic networks. The European Union places particular weight on authorization, welfare, traceability, and prudent antimicrobial use. G7 economies generally combine sophisticated veterinary services with demanding standards for safety, evidence, and stewardship. GCC markets are strongly influenced by import dependence, food-security policy, and climatic stress. NATO members do not form a single swine-health market, but their overlapping emphasis on supply-chain resilience, biosecurity, and emergency preparedness can support coordinated risk-management practices.

Country-Level Priorities Differ by Production Structure and Regulation

Australia emphasizes biosecurity and protection from exotic disease threats. Brazil requires solutions suited to large-scale production, regional disease variation, and export-oriented controls. Canada benefits from coordinated veterinary systems while managing seasonal and transport-related risks. China combines large commercial production with substantial variation in farm structure and disease-control practice. France, Germany, Italy, and Spain operate within European regulatory and stewardship expectations, with strong attention to welfare, traceability, and respiratory health. India has a diverse and developing swine sector in which access, awareness, and veterinary support influence uptake. Japan and South Korea rely on structured production systems and stringent quality expectations, while managing dense-farm biosecurity. Mexico faces varied production formalization and cross-border considerations. Russia requires attention to regional production differences, domestic supply continuity, and regulatory processes. The United Kingdom places emphasis on biosecurity, welfare, responsible medicine use, and resilient supply chains. The United States combines advanced herd-health services with strong focus on production consistency, antimicrobial stewardship, and data-supported veterinary decisions.

Leadership Priorities for More Resilient Vaccination Programs

Industry leaders should first map pathogen risk by production stage, geography, and herd type, then align vaccination protocols with validated diagnostics and measurable outcomes such as respiratory scores, mortality, growth, and treatment use. They should maintain documented cold-chain and administration controls, train personnel, audit compliance, and establish veterinary review points for protocol changes. Investment in interoperable records and carefully governed analytics can improve early warning without weakening clinical accountability. Leaders should also qualify multiple supply and logistics pathways, engage regulators early, communicate clearly with producers, and integrate vaccination with biosecurity, ventilation, stocking-density management, and antimicrobial-stewardship plans.

Methodology for a Evidence-Based Executive Assessment

This assessment uses the defined market scope-vaccines addressing porcine circovirus and Mycoplasma hyopneumoniae-and synthesizes established veterinary, regulatory, epidemiological, and production-management considerations. The analysis is organized across the required regions, economic and policy groups, and countries, with emphasis on determinants of adoption, implementation, surveillance, and risk management. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific comparisons. Interpretations should be validated against current product labels, national authorization requirements, local disease surveillance, laboratory evidence, and veterinary guidance before operational use.

Conclusion: Prevention Works Best as a Measured Herd-System Strategy

Porcine circovirus-Mycoplasma hyopneumoniae vaccination is most effective when treated as one component of an integrated herd-health system rather than as a stand-alone intervention. Regional regulation, production structure, biosecurity, diagnostics, logistics, and antimicrobial policies materially shape outcomes. The strongest leadership approach combines evidence-based protocols, disciplined execution, measurable monitoring, responsible data use, and continuous veterinary review to improve resilience across diverse swine-production environments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market, by Vaccine Type
7.1. Introduction
7.2. Combination Vaccine
7.3. Monovalent Vaccine
8. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market, by Dosage Form
8.1. Introduction
8.2. Liquid For Injection
8.2.1. Multidose Vial
8.2.2. Single Dose Vial
8.3. Lyophilized Powder For Injection
9. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market, by Administration Route
9.1. Introduction
9.2. Intramuscular Injection
9.3. Subcutaneous Injection
10. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market, by Animal Age Group
10.1. Introduction
10.2. Finishers
10.3. Grower Pigs
10.4. Sows
10.5. Weaner Pigs
11. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market, by Sales Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distribution Partners
11.4. Online Channel
12. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market, by End User
12.1. Introduction
12.2. Animal Farms
12.3. Research Laboratories
12.4. Veterinary Clinics
13. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Boehringer Ingelheim International GmbH
17.2. Ceva Santé Animale S.A.
17.3. Elanco Animal Health Incorporated
17.4. Hipra, S.A.
17.5. Indian Immunologicals Limited
17.6. Merck & Co., Inc.
17.7. Pharmgate Animal Health Private Limited
17.8. Phibro Animal Health Corporation
17.9. Wuhan Keqian Biology Co., Ltd.
17.10. Zoetis Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market, Years Considered for the Study
FIGURE 2. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market, Research Design
FIGURE 3. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market, Research Framework
FIGURE 4. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market, Data Triangulation
FIGURE 5. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2025 vs 2032 (%)
FIGURE 7. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 9. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2025 vs 2032 (%)
FIGURE 11. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2025 vs 2032 (%)
FIGURE 13. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2025 vs 2032 (%)
FIGURE 15. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Segmentation & Coverage
TABLE 2. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, 2017-2032 (USD Million)
TABLE 3. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 4. Global Combination Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Combination Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Combination Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Monovalent Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Monovalent Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Monovalent Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 11. Global Liquid For Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Liquid For Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Liquid For Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Multidose Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Multidose Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Multidose Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Single Dose Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Single Dose Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Single Dose Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Lyophilized Powder For Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Lyophilized Powder For Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Lyophilized Powder For Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 24. Global Intramuscular Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Intramuscular Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Intramuscular Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Subcutaneous Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Subcutaneous Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Subcutaneous Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 31. Global Finishers Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Finishers Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Finishers Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Grower Pigs Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Grower Pigs Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Grower Pigs Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Sows Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Sows Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Sows Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Weaner Pigs Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Weaner Pigs Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Weaner Pigs Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 44. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Distribution Partners Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Distribution Partners Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Distribution Partners Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Online Channel Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Online Channel Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Online Channel Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 54. Global Animal Farms Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Animal Farms Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Animal Farms Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Research Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Research Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Research Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Veterinary Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Veterinary Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Veterinary Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 72. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 74. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 75. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 76. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 77. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 78. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 79. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 80. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 82. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 83. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 84. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 85. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 86. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 87. Latin America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 88. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 90. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 91. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 92. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 93. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 94. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 95. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Middle East Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Middle East Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 98. Middle East Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 99. Middle East Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 100. Middle East Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 101. Middle East Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 102. Middle East Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 103. Middle East Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 106. Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 107. Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 108. Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 109. Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 110. Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 111. Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 112. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. ASEAN Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. ASEAN Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 115. ASEAN Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 116. ASEAN Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 117. ASEAN Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 118. ASEAN Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 119. ASEAN Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 120. ASEAN Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. GCC Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. GCC Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 123. GCC Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 124. GCC Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 125. GCC Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 126. GCC Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 127. GCC Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 128. GCC Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. European Union Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. European Union Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 131. European Union Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 132. European Union Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 133. European Union Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 134. European Union Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 135. European Union Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 136. European Union Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 137. BRICS Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. BRICS Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 139. BRICS Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 140. BRICS Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 141. BRICS Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 142. BRICS Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 143. BRICS Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 144. BRICS Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. G7 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. G7 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 147. G7 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 148. G7 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 149. G7 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 150. G7 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 151. G7 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 152. G7 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. NATO Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. NATO Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 155. NATO Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 156. NATO Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 157. NATO Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 158. NATO Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 159. NATO Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 160. NATO Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 162. United States Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, 2017-2032 (USD Million)
TABLE 163. United States Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 164. United States Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 165. United States Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 166. United States Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 167. United States Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 168. United States Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 169. United States Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. Canada Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, 2017-2032 (USD Million)
TABLE 171. Canada Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 172. Canada Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 173. Canada Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 174. Canada Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 175. Canada Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 176. Canada Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 177. Canada Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Mexico Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, 2017-2032 (USD Million)
TABLE 179. Mexico Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 180. Mexico Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 181. Mexico Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 182. Mexico Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 183. Mexico Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 184. Mexico Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 185. Mexico Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. Brazil Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, 2017-2032 (USD Million)
TABLE 187. Brazil Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 188. Brazil Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 189. Brazil Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 190. Brazil Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 191. Brazil Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 192. Brazil Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 193. Brazil Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. United Kingdom Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, 2017-2032 (USD Million)
TABLE 195. United Kingdom Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 196. United Kingdom Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 197. United Kingdom Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 198. United Kingdom Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 199. United Kingdom Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 200. United Kingdom Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 201. United Kingdom Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. Germany Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, 2017-2032 (USD Million)
TABLE 203. Germany Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 204. Germany Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 205. Germany Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 206. Germany Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 207. Germany Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 208. Germany Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 209. Germany Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. France Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, 2017-2032 (USD Million)
TABLE 211. France Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 212. France Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 213. France Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 214. France Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 215. France Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 216. France Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 217. France Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. Russia Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, 2017-2032 (USD Million)
TABLE 219. Russia Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 220. Russia Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 221. Russia Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 222. Russia Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 223. Russia Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 224. Russia Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 225. Russia Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. Italy Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, 2017-2032 (USD Million)
TABLE 227. Italy Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 228. Italy Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 229. Italy Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 230. Italy Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 231. Italy Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 232. Italy Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 233. Italy Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. Spain Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, 2017-2032 (USD Million)
TABLE 235. Spain Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 236. Spain Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 237. Spain Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 238. Spain Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 239. Spain Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 240. Spain Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 241. Spain Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. China Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, 2017-2032 (USD Million)
TABLE 243. China Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 244. China Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 245. China Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 246. China Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 247. China Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 248. China Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 249. China Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. India Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, 2017-2032 (USD Million)
TABLE 251. India Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 252. India Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 253. India Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 254. India Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 255. India Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 256. India Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 257. India Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 258. Japan Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, 2017-2032 (USD Million)
TABLE 259. Japan Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 260. Japan Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 261. Japan Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 262. Japan Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 263. Japan Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 264. Japan Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 265. Japan Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. Australia Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, 2017-2032 (USD Million)
TABLE 267. Australia Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 268. Australia Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 269. Australia Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 270. Australia Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 271. Australia Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 272. Australia Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 273. Australia Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. South Korea Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, 2017-2032 (USD Million)
TABLE 275. South Korea Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 276. South Korea Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 277. South Korea Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Liquid For Injection, 2017-2032 (USD Million)
TABLE 278. South Korea Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 279. South Korea Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Animal Age Group, 2017-2032 (USD Million)
TABLE 280. South Korea Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, by Sal

Companies Mentioned

  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Elanco Animal Health Incorporated
  • Hipra, S.A.
  • Indian Immunologicals Limited
  • Merck & Co., Inc.
  • Pharmgate Animal Health Private Limited
  • Phibro Animal Health Corporation
  • Wuhan Keqian Biology Co., Ltd.
  • Zoetis Inc.

Related Topics

Related Reports

Swine Vaccines Market - Global Forecast 2026-2032 - Product Image

Swine Vaccines Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Swine Vaccines Market - Global Strategic Business Report - Product Image

Swine Vaccines Market - Global Strategic Business Report

  • Report
  • 398 Pages
  • Global
From
Veterinary Vaccines Market Report 2026 - Product Image

Veterinary Vaccines Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Swine Vaccines Market Report 2026 - Product Image

Swine Vaccines Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Swine Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Swine Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 177 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.